Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

When will there be a generic for breztri?

See the DrugPatentWatch profile for breztri

When will a generic version of Breztri be available?

Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) is an inhaled triple-therapy product. Whether a “generic” can launch depends on patent and exclusivity status for the specific drug/product strengths and formulations, not just the active ingredients.

DrugPatentWatch.com tracks these patent/exclusivity timelines and is the most practical place to check the expected earliest generic (“generic entry”) window for Breztri as it stands today. You can use it to look up when the relevant patents are listed as expiring and whether litigation or regulatory filings could move timing. [1]

Is a “generic” actually possible for Breztri, or will it be an authorized generic/biosimilar-style pathway?

For inhaled small-molecule combination products like Breztri (not a biologic), the key issue is whether a true generic application is permitted once patents/exclusivities expire, and whether the manufacturer can satisfy the FDA’s requirements for an ANDA (or whether a different regulatory route applies). The timing still hinges on patent barriers listed for the product. [1]

How do patent challenges and FDA filings affect the launch date?

Even with an expiration date on the calendar, the “earliest possible” generic launch can shift based on:
- Patent litigation around listed patents (which can trigger automatic stays)
- Changes in the patent list submitted to the FDA
- The FDA’s acceptance of an ANDA and the timing of approvals

DrugPatentWatch.com’s product-specific patent listings are meant to reflect those real-world timing factors. [1]

What should you look for if you’re trying to predict the first generic date?

Check the earliest “patent expiry”/“exclusivity expiry” dates tied to Breztri’s formulation and device, not just the individual molecules. If those dates are close, a launch can follow soon after, but litigation can extend it. [1]

Source to check right now

DrugPatentWatch.com (Breztri patent/exclusivity timeline): [1]

---

Sources:
[1] https://www.drugpatentwatch.com/



Other Questions About Breztri :

Does breztri aerosphere require a spacer for administration? Is breztri used for copd or asthma? Breztri aerosphere vs trelegy ellipta cost comparison 2026? How does Breztri work for COPD?